Aptar Digital Health Partners With Chiesi Group To Market Aptar’s Disease Management Platform For Asthma & COPD

Aptar Digital Health partnered with the Chiesi Group, an international research-focused biopharmaceutical and health care group, to commercialize Aptar’s newly announced disease management platform to support consumers with asthma and chronic obstructive pulmonary disease (COPD). Aptar Digital Health is a division of Aptar Pharma, part of AptarGroup. The partnership initially focuses on Europe, with potential future expansions to other geographies.

The new asthma and COPD platform expands Aptar Pharma's portfolio of digital health solutions with a complete, end-to-end solution, supporting consumers from the prevention and diagnosis phases, to disease management, and more across multiple therapeutic . . .